Liam Krueger, Atheer Awad, Abdul W. Basit, Alvaro Goyanes, Jared A. Miles, Amirali Popat
{"title":"3D 打印药品的临床转化","authors":"Liam Krueger, Atheer Awad, Abdul W. Basit, Alvaro Goyanes, Jared A. Miles, Amirali Popat","doi":"10.1038/s44222-024-00217-x","DOIUrl":null,"url":null,"abstract":"The versatility of three-dimensional printed pharmaceuticals, relative to traditionally manufactured ones, could be leveraged for personalized treatment at the point of care, as well as being integrated into mass-manufacturing pipelines. Improvements in quality control and collaboration with regulatory bodies will pave the way to large-scale clinical translation.","PeriodicalId":74248,"journal":{"name":"Nature reviews bioengineering","volume":"2 10","pages":"801-803"},"PeriodicalIF":37.6000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical translation of 3D printed pharmaceuticals\",\"authors\":\"Liam Krueger, Atheer Awad, Abdul W. Basit, Alvaro Goyanes, Jared A. Miles, Amirali Popat\",\"doi\":\"10.1038/s44222-024-00217-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The versatility of three-dimensional printed pharmaceuticals, relative to traditionally manufactured ones, could be leveraged for personalized treatment at the point of care, as well as being integrated into mass-manufacturing pipelines. Improvements in quality control and collaboration with regulatory bodies will pave the way to large-scale clinical translation.\",\"PeriodicalId\":74248,\"journal\":{\"name\":\"Nature reviews bioengineering\",\"volume\":\"2 10\",\"pages\":\"801-803\"},\"PeriodicalIF\":37.6000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature reviews bioengineering\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.nature.com/articles/s44222-024-00217-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature reviews bioengineering","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44222-024-00217-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clinical translation of 3D printed pharmaceuticals
The versatility of three-dimensional printed pharmaceuticals, relative to traditionally manufactured ones, could be leveraged for personalized treatment at the point of care, as well as being integrated into mass-manufacturing pipelines. Improvements in quality control and collaboration with regulatory bodies will pave the way to large-scale clinical translation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
